|
|
CrossCart Announces FDA Approval of Pivotal Clinical Trial and Appointment of Roy Fiebiger as CEO
CrossCart
|
CrossCart, Inc., a leading developer of xenograft tissue technology, announced today that it received conditional FDA approval to conduct a pivotal clinical trial for its Z-LigTM porcine derived anterior cruciate ligament (ACL) device. Separately, ...
Read More
This press release is about: crosscart, crosscart’s, fiebiger, device, clinical, tissue, surgical, announced, z-ligtm, medical, pivotal
Published: 2004-10-15
|
|
|
|
|
|
|
Browse Press Releases: 0-9
A B
C D
E F
G H
I J
K L
M N
O P
Q R
S T
U V
W X
Y Z
|
|
|
« June,2006
|
| S |
M |
T |
W |
T |
F |
S |
|
|
|
|
1 |
2 |
3 |
| 4 |
5 |
6 |
7 |
8 |
9 |
10 |
| 11 |
12 |
13 |
14 |
15 |
16 |
17 |
| 18 |
19 |
20 |
21 |
22 |
23 |
24 |
| 25 |
26 |
27 |
28 |
29 |
30 |
|
|
|